Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $57.9 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) rose 1.09% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 1.09%. This contributed to the annual value of $57.9 million for FY2024, which is 4.15% down from last year.
  • Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) amounted to $57.9 million in FY2024, which was down 4.15% from $60.4 million recorded in FY2023.
  • Harmony Biosciences Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $61.1 million for FY2022, and its period low was $25.8 million during FY2020.
  • Over the past 3 years, Harmony Biosciences Holdings' median Shares Outstanding (Diluted Average) value was $60.4 million (recorded in 2023), while the average stood at $59.8 million.
  • In the last 5 years, Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) soared by 231.37% in 2020 and then decreased by 4.15% in 2024.
  • Yearly analysis of 5 years shows Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) stood at $25.8 million in 2020, then skyrocketed by 129.72% to $59.2 million in 2021, then climbed by 3.20% to $61.1 million in 2022, then fell by 1.19% to $60.4 million in 2023, then fell by 4.15% to $57.9 million in 2024.